Canada Life
RGEN icon

Canada Life’s Repligen RGEN Stock Holding History

Canada Life’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.67M Buy
31,082
+309
+1% +$43.2K 0.01% 879
2025
Q4 		$5.04M Sell
30,773
-5,826
-16% -$913K 0.01% 742
2025
Q3 		$4.54M Buy
36,599
+100
+0.3% +$12.1K 0.01% 856
2025
Q2 		$4.54M Sell
36,499
-1,429
-4% -$182K 0.01% 827
2025
Q1 		$4.83M Sell
37,928
-3,247
-8% -$500K 0.01% 801
2024
Q4 		$5.92M Buy
41,175
+6,200
+18% +$889K 0.01% 757
2024
Q3 		$5.21M Sell
34,975
-9,223
-21% -$1.32M 0.01% 843
2024
Q2 		$5.57M Buy
44,198
+5,639
+15% +$884K 0.01% 761
2024
Q1 		$7.09M Buy
38,559
+567
+1% +$108K 0.01% 661
2023
Q4 		$6.82M Sell
37,992
-150
-0.4% -$23.4K 0.02% 647
2023
Q3 		$6.06M Sell
38,142
-2,073
-5% -$339K 0.01% 650
2023
Q2 		$5.7M Sell
40,215
-5,183
-11% -$831K 0.01% 665
2023
Q1 		$7.64M Buy
45,398
+3,447
+8% +$615K 0.02% 598
2022
Q4 		$7.1M Buy
41,951
+6,669
+19% +$1.21M 0.02% 600
2022
Q3 		$6.6M Buy
35,282
+3,487
+11% +$735K 0.02% 600
2022
Q2 		$5.16M Buy
31,795
+3,669
+13% +$580K 0.01% 692
2022
Q1 		$5.43M Buy
28,126
+2,143
+8% +$407K 0.01% 735
2021
Q4 		$6.88M Buy
25,983
+2,004
+8% +$540K 0.01% 678
2021
Q3 		$6.97M Buy
23,979
+4,174
+21% +$1.07M 0.02% 658
2021
Q2 		$3.95M Buy
19,805
+107
+0.5% +$20.8K 0.01% 788
2021
Q1 		$3.83M Sell
19,698
-1,331
-6% -$273K 0.01% 792
2020
Q4 		$4.03M Sell
21,029
-2,133
-9% -$388K 0.01% 823
2020
Q3 		$3.41M Sell
23,162
-362
-2% -$51.7K 0.01% 841
2020
Q2 		$2.91M Sell
23,524
-713
-3% -$83.9K 0.01% 896
2020
Q1 		$2.34M Buy
24,237
+1,596
+7% +$154K 0.01% 878
2019
Q4 		$2.08M Buy
22,641
+356
+2% +$29.9K ﹤0.01% 1111
2019
Q3 		$1.71M Sell
22,285
-33,952
-60% -$2.97M ﹤0.01% 834
2019
Q2 		$4.83M Buy
56,237
+4,119
+8% +$281K 0.01% 742
2019
Q1 		$3.08M Sell
52,118
-231
-0.4% -$13.3K 0.01% 820
2018
Q4 		$2.55M Buy
52,349
+6,208
+13% +$364K 0.01% 884
2018
Q3 		$2.56M Sell
46,141
-1,812
-4% -$93.4K 0.01% 1002
2018
Q2 		$2.25M Sell
47,953
-1,292
-3% -$53.2K 0.01% 1100
2018
Q1 		$1.78M Buy
49,245
+64
+0.1% +$2.25K ﹤0.01% 1219
2017
Q4 		$1.78M Sell
49,181
-1,450
-3% -$52.5K ﹤0.01% 1247
2017
Q3 		$1.91M Sell
50,631
-2,702
-5% -$113K ﹤0.01% 1189
2017
Q2 		$2.21M Buy
53,333
+4,930
+10% +$187K 0.01% 1083
2017
Q1 		$1.7M Buy
48,403
+3,964
+9% +$126K ﹤0.01% 1237
2016
Q4 		$1.37M Sell
44,439
-1,243
-3% -$38.4K ﹤0.01% 1322
2016
Q3 		$1.38M Buy
45,682
+2,718
+6% +$82K ﹤0.01% 1281
2016
Q2 		$1.17M Buy
42,964
+39,064
+1,002% +$999K ﹤0.01% 1337
2016
Q1 		$104K Hold
3,900
– – ﹤0.01% 1773
2015
Q4 		$110K Hold
3,900
– – ﹤0.01% 1698
2015
Q3 		$109K Hold
3,900
– – ﹤0.01% 1643
2015
Q2 		$160K Hold
3,900
– – ﹤0.01% 1511
2015
Q1 		$118K Hold
3,900
– – ﹤0.01% 1695
2014
Q4 		$77K Hold
3,900
– – ﹤0.01% 1909
2014
Q3 		$78K Buy
+3,900
New +$82.1K ﹤0.01% 1857

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Canada Life's RGEN Position: Q1 2026 in Review

Canada Life increased its Repligen (RGEN) stake by 1% in Q1 2026, buying an estimated $43.2K and bringing the position to 31,082 shares worth $3.67M. The position accounts for 0.01% of the portfolio, ranked #879.

Canada Life first reported a position in RGEN in Q3 2014 and has held it in 47 quarters since. The position peaked at $7.64M in Q1 2023. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Canada Life held 31,082 shares of Repligen worth $3.67M as of Q1 2026.
  • Canada Life bought 309 Repligen shares in Q1 2026, an estimated $43.2K.
  • Repligen made up 0.01% of Canada Life's portfolio in Q1 2026, its #879 holding.
  • Canada Life first reported a position in Repligen in Q3 2014 and has held it in 47 quarters since.
  • Canada Life's Repligen position peaked at $7.64M in Q1 2023.
  • 442 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.